Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s560731 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Lingyan Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China. Hauptthemen laut MEDLINE: Clobazam, Drug Resistant Epilepsy, Anticonvulsants, Benzodiazepines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.
- Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou, 310058, People's Republic of China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
- Shenzhen Children's Hospital, Shenzhen, 518026, People's Republic of China.
- First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, 230001, People's Republic of China.
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, People's Republic of China.
ORCID-Profile: Lingyan Yu, Zhou Zhang, Zhenwei Yu, Xuejuan Li, Haibin Dai
Zitieren
APA
Yu, L., Chen, S., Zhang, Z., Hu, Y., Fang, Y., Mao, F., Wang, S., Yu, Z., Li, X., & Dai, H. (2025). Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s560731
Vancouver
Yu L, Chen S, Zhang Z, Hu Y, Fang Y, Mao F, et al. Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s560731
BibTeX
@article{Yu2025,
author = {Yu, Lingyan and Chen, Shunan and Zhang, Zhou and Hu, Yani and Fang, Yuting and Mao, Fengqian and Wang, Suhong and Yu, Zhenwei and Li, Xuejuan and Dai, Haibin},
title = {Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s560731}
}
EUVIMED